Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term

Boston Scientific (BSX), despite holding a Zacks Rank #3 (Hold), is presented as a strong growth prospect, underscored by a Growth Style Score of B and a projected 18.7% year-over-year earnings growth for the current fiscal year. The company has seen significant positive analyst revisions for 2025, with 11 analysts increasing estimates in the last 60 days, raising the Zacks Consensus Estimate by $0.07 to $2.98 per share, complemented by an average earnings surprise of +8.1%. This combination of robust growth metrics and upward earnings revisions positions BSX as a notable consideration for growth-oriented investors.

Analysis

Boston Scientific (BSX) exhibits strong underlying growth fundamentals despite its neutral Zacks Rank of #3 (Hold). The company is projected to achieve an 18.7% year-over-year earnings growth for the current fiscal year, supported by a favorable "B" rating in both its Growth and overall VGM Style Scores. Analyst sentiment is notably positive and strengthening, with 11 analysts revising fiscal 2025 earnings estimates higher over the last 60 days. This consensus shift has lifted the fiscal 2025 earnings estimate by $0.07 to $2.98 per share. Furthermore, BSX has a consistent track record of outperformance, evidenced by an average positive earnings surprise of 8.1%. The combination of a robust growth outlook and upward earnings revisions suggests a compelling fundamental picture that may warrant closer inspection beyond the headline "Hold" rating.

Key Decisions for Investors

• Growth-oriented investors should view the combination of 18.7% projected earnings growth and the significant upward revisions from 11 analysts as a strong bullish indicator for the company's fundamental trajectory.
• Despite the strong growth metrics, the neutral #3 (Hold) rating suggests investors should conduct further diligence on potential headwinds, such as valuation or market positioning, that might be constraining the stock's near-term rating.
• Given the history of an 8.1% average earnings surprise, investors should closely monitor upcoming quarterly reports, as continued outperformance could serve as a key catalyst for a potential ratings upgrade and subsequent share price momentum.